CXCL12 and limb ischemia: Taken together, these findings suggest that in the mouse HLI model, SDF1α-eMSCs provided a favorable microenvironment for vascular regeneration and skeletal muscle repair in the early stages of limb ischemia by facilitating arterialization, modulating inflammation and protecting against skeletal muscle damage (Fig. 7d).